RBC Capital raised the firm’s price target on Karman (KRMN) to $93 from $78 and keeps an Outperform rating on the shares as part of its broader ...

RBC Capital raised the firm’s price target on CN (CNI) to C$158 from C$148 and keeps an Outperform rating on the shares. The company’s Q3 saw an ...

Mobico Group's stock forecast has been updated, with analysts reiterating a fair value estimate of £0.39 per share. The latest assessment comes as discount rates remain steady and only minor revisions ...

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that data from the ongoing Phase 1b study of R2891, a ...

Canadian prime minister Mark Carney presents his first budget on Tuesday, having recruited a host of private sector ...

Shares lower; Westpac profit down on ‘persistent competition’ for lending; Healthscope pays all deferred rent to HealthCo ...